Demonstrating continuing support for immuno-oncology researchers, BioIVT extends excellence in research to help researchers screen novel therapeutics WESTBURY, N.Y. — BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research. […]

World-class facility will offer the Company nearly three times the space for disruptive biomarker technology innovation and to accommodate growing pharma services business BILLERICA, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the relocation of its headquarters to a brand new, state-of-the-art facility in Billerica, […]

The first commercially available targeted NGS assay that enables simultaneous detection of somatic variants across 53 solid tumor genes using a highly efficient microfluidic library prep workflow SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today introduced the Advanta™ Solid Tumor NGS […]

Introducing the most comprehensive commercially available NGS assay for detecting gene fusions in cancer using an automated nanoscale library prep workflow SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today introduced the Advanta™ RNA Fusions NGS Library Prep Assay for detection of over 380 […]

WINOOSKI VT, USA — BioTek Instruments announces a new wide field of view (FOV) camera option for their Cytation 5 Cell Imaging Multi-Mode Reader. The new wide FOV camera captures approximately four times the area compared to Cytation 5’s standard camera, allowing users to capture larger areas of interest with fewer images. The new camera increases […]

New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing. […]

SAN JOSE, Calif. — Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware. The lawsuit alleges that a number of genetic sequencers and related reagents from Illumina, including the NovaSeq 6000, NextSeq series, and MiniSeq, are infringing Complete Genomics’ U.S. Patent No. 9,222,132 […]

At Benchling, we’ve been fortunate to support scientists doing some of the world’s most groundbreaking research—from designing CRISPR experiments and engineering CAR T cells to producing novel biomaterials. Over the years, more than 170,000 scientists have depended on Benchling to design DNA, collaborate on experiments, and manage complex research workflows. Many of these scientists are […]

USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]

VANCOUVER – Two million Canadian children are classified as having a rare disease. As these children and their families navigate these complex, life-threatening, or chronically debilitating conditions, their stories are often similar — they spend years experiencing a diagnostic odyssey that includes many hospital and clinic visits, tests and several misdiagnoses before a firm diagnosis is […]